MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice

2017/03/18 by Hayk Davtyan, Wesley W. Chen, Karen Zagorski +8 · 17 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Alzheimer's disease research and treatments #Antibody #Biology #DNA vaccination #Disease #ELISPOT #Epitope #Genetically modified mouse #Immune system #Immunization #Immunohistochemistry #Immunology #Medicinal Plants and Neuroprotection #Medicine #Neurodegeneration #Pathology #T cell #Tauopathy #Transgene #Transgenic Plants and Applications #Vaccination

paper · doi:10.1016/j.vaccine.2017.03.020

openalex publication_date 2017/03/18 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Cited by

• Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls. [europepmc]
• Tau-targeting therapies for Alzheimer disease. [europepmc]
• Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead. [europepmc]
• Efficacy and Safety of the Immunization with DNA for Alzheimer's Disease in Animal Models: A Systematic Review from Literature. [europepmc]
• A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice. [europepmc]
• Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice. [europepmc]
• Tau immunotherapies: Lessons learned, current status and future considerations. [europepmc]
• Current Status of Clinical Trials on Tau Immunotherapies. [europepmc]
• Novel Therapies for Parkinsonian Syndromes-Recent Progress and Future Perspectives. [europepmc]
• Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives. [europepmc]
• Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies. [europepmc]
• Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein. [europepmc]
• Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates. [europepmc]
• Multipronged diagnostic and therapeutic strategies for Alzheimer's disease. [europepmc]
• Summary of the Current Status of DNA Vaccination for Alzheimer Disease. [europepmc]
• Alzheimer's Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective. [europepmc]
• Tau-targeting active immunotherapy slows progression and reduces pathology in mouse models of tauopathy. [europepmc]